Clinical Trial Update: Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating early administration of glargine (Lantus) in the management of diabetic ketoacidosis in children with type 1 diabetes; complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Ketoacidosis
• Type 1 Diabetes Mellitus

Drugs mentioned

• Glargine (insulin glargine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetic Ketoacidosis, Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2022-05-10